If you’re on antidepressants, psilocybin may be safer than MDMA
Psilocybin safer to take with psychiatric medications than MDMA, researchers say An analysis of 40 publications found
March 10, 2022
Psilocybin safer to take with psychiatric medications than MDMA, researchers say An analysis of 40 publications found
Global Wellness Strategies Signs MDMA Supply Agreement with PharmAla Biotech Vancouver, British Columbia, February 10,
Mydecine’s Exclusive Dealer Identified as Licensed Psilocybin and MDMA Supplier in Canada Mydecine now able
Can MDMA Save a Marriage? A couple was on the verge of getting divorced until
Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA
MAPS is Granted Innovation Passport in United Kingdom for MDMA as an Adjunct to Therapy
Subjective effects of MDMA (‘Ecstasy’) on human sexual function Over 90% of people experienced increased
Global Wellness’ Shanti Therapeutics Announce Psychedelic Drug Development Agreement Vancouver, British Columbia, January 20, 2022 –
Awakn Life Sciences Signs MOU With MAPS Agreement to explore a partnership for MDMA-Assisted Therapy
Survey Finds Majority of Affected Americans Approve of Psychedelics as an Alternative Treatment to Address
Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical Trial Numinus Wellness (NUMI)
Sydney Researchers Awarded Over $2.2 Million By Australian Government To Study MDMA, Psilocybin University of
Mydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted
Latest Trials Confirm the Benefits of MDMA – the Drug in Ecstasy – for Treating
Mycrodose Therapeutics Receives DEA License to Research Four Psychedelics Mycrodose Therapeutics is pleased to announce that
Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel HaluGen Life Sciences expanded its psychedelic DNA
Psychedelics: The newest tool in nuclear negotiations? This scientist claims she helped end the Cold
MAPS and Wesana Health Resume Negotiations Analysis indicates viability of research pathway for MDMA-assisted therapy
MAPS and Vine Ventures Pioneer Novel Regenerative Funding Structure to Infuse Psychedelic-Assisted Therapy Research and
Global Wellness’ Shanti Therapeutics Submits Human Research Ethics Committee (HREC) Application Shanti Therapeutics, a subsidiary
Australian Psychiatrist Sues State Of Victoria For Denying MDMA Treatment For Ailing Patient A psychiatrist
DEA Boosts Psilocybin, MDMA And DMT Production Levels Again In Final Quotas For 2021 To
Numinus to Host Extension of MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials Numinus will manage two
MINDCURE Provides Update on Studies and Clinical Trials VANCOUVER, BC, Nov. 4, 2021 /CNW/ – Mind